Baxter Enters into Drug Development Collaboration

Baxter International, a provider of renal and hospital products, said early Wednesday that it has entered into an agreement with India-based Dorizoe Lifesciences Limited that will facilitate the accelerated development of more than 20 generic injectable products.

Under the deal, Dorizoe will work with Baxter to perform certain product development activities, while Baxter will hold worldwide manufacturing and commercialization rights for the products. The deal covers anti-infectives, oncolytics, and cardiovascular medicines.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Comment